Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Histrelin Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 Supprelin LA
  • 1.4.3 Vantas
• 1.5 Market by Application
  • 1.5.1 Global Histrelin Market Share by Application (2014-2025)
  • 1.5.2 Boy
  • 1.5.3 Girl
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Histrelin Market Size
• 2.2 Histrelin Growth Trends by Regions
  • 2.2.1 Histrelin Market Size by Regions (2014-2025)
  • 2.2.2 Histrelin Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Opportunities

3 Market Share by Key Players

• 3.1 Histrelin Market Size by Manufacturers
  • 3.1.1 Global Histrelin Revenue by Manufacturers (2014-2019)
  • 3.1.2 Global Histrelin Revenue Market Share by Manufacturers (2014-2019)
  • 3.1.3 Global Histrelin Market Concentration Ratio (CR5 and HHI)
• 3.2 Histrelin Key Players Head office and Area Served
• 3.3 Key Players Histrelin Product/Solution/Service
• 3.4 Date of Enter into Histrelin Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Histrelin Market Size by Type (2014-2019)
• 4.2 Global Histrelin Market Size by Application (2014-2019)

5 United States

• 5.1 United States Histrelin Market Size (2014-2019)
• 5.2 Histrelin Key Players in United States
• 5.3 United States Histrelin Market Size by Type
• 5.4 United States Histrelin Market Size by Application

6 Europe

• 6.1 Europe Histrelin Market Size (2014-2019)
• 6.2 Histrelin Key Players in Europe
• 6.3 Europe Histrelin Market Size by Type
• 6.4 Europe Histrelin Market Size by Application

7 China

• 7.1 China Histrelin Market Size (2014-2019)
• 7.2 Histrelin Key Players in China
• 7.3 China Histrelin Market Size by Type
• 7.4 China Histrelin Market Size by Application

8 Japan

• 8.1 Japan Histrelin Market Size (2014-2019)
• 8.2 Histrelin Key Players in Japan
• 8.3 Japan Histrelin Market Size by Type
• 8.4 Japan Histrelin Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Histrelin Market Size (2014-2019)
• 9.2 Histrelin Key Players in Southeast Asia
• 9.3 Southeast Asia Histrelin Market Size by Type
• 9.4 Southeast Asia Histrelin Market Size by Application

10 India

• 10.1 India Histrelin Market Size (2014-2019)
• 10.2 Histrelin Key Players in India
• 10.3 India Histrelin Market Size by Type
• 10.4 India Histrelin Market Size by Application

11 Central & South America

• 11.1 Central & South America Histrelin Market Size (2014-2019)
• 11.2 Histrelin Key Players in Central & South America
• 11.3 Central & South America Histrelin Market Size by Type
• 11.4 Central & South America Histrelin Market Size by Application

12 International Players Profiles

• 12.1 Endo Pharmaceuticals
  • 12.1.1 Endo Pharmaceuticals Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Histrelin Introduction
  • 12.1.4 Endo Pharmaceuticals Revenue in Histrelin Business (2014-2019)
  • 12.1.5 Endo Pharmaceuticals Recent Development

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Regions
• 13.2 United States
• 13.3 Europe
• 13.4 China
• 13.5 Japan
• 13.6 Southeast Asia
• 13.7 India
• 13.8 Central & South America
• 13.9 Market Size Forecast by Product (2019-2025)
• 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 12.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer

Histrelin acetate, sold under the brand names Vantas and Supprelin LA among others, is a nonapeptide analogue of gonadotropin-releasing hormone (GnRH) with added potency. When present in the bloodstream, it acts on particular cells of the pituitary gland called gonadotropes. Histrelin stimulates these cells to release luteinizing hormone and follicle-stimulating hormone. Thus it is considered a gonadotropin-releasing hormone agonist or GnRH agonist.
In 2018, the global Histrelin market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Histrelin status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Histrelin development in United States, Europe and China.

The key players covered in this study
Endo Pharmaceuticals
...

Market segment by Type, the product can be split into
Supprelin LA
Vantas

Market segment by Application, split into
Boy
Girl

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Histrelin status, future forecast, growth opportunity, key market and key players.
To present the Histrelin development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Histrelin are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.